← Back to patent-cliff list
CAS 1023742-13-3
O-(2-(tert-butoxy)ethyl)hydroxylamine
Codes：BINI-020
Application context (from source-drug indications)
非小细胞肺癌贝美替尼黑色素瘤贝美替尼结直肠癌贝美替尼毛细胞白血病贝美替尼丛状神经纤维瘤贝美替尼神经纤维瘤病I型贝美替尼
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 贝美替尼Binimetinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,3,4-trifluorobenzoic acid→2,3,4-trifluoro-5-nitrobenzoic acid→4-amino-2,3-difluoro-5-nitrobenzoic acid→methyl 4-amino-2,3-difluoro-5-nitrobenzoate→methyl 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate→methyl 2,4-diamino-3-fluoro-5-nitrobenzoate→methyl 2,4,5-triamino-3-fluorobenzoate→diethoxymethane→methyl 5-amino-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate→4-bromo-2-fluoro-1-iodobenzene→potassium 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate→(5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazol-6-yl)(1H-imidazol-1-yl)methanone→O-(2-(tert-butoxy)ethyl)hydroxylamine→5-((4-bromo-2-fluorophenyl)amino)-N-(2-(tert-butoxy)ethoxy)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxamide hydrate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.